Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SKOPOULI, F. N.
Right arrow Articles by MOUTSOPOULOS, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SKOPOULI, F. N.
Right arrow Articles by MOUTSOPOULOS, H. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 British Society for Rheumatology

research-article

LIVER INVOLVEMENT IN PRIMARY SJÖGREN'S SYNDROME

F. N. SKOPOULI, C. BARBATIS and H. M. MOUTSOPOULOS

*Department of Internal Medicine, Medical School, University of Ioannuna Athens, Greece
{dagger}Department of Pathology, Red Cross Hospital of Athens Athens, Greece
{ddagger}Department of Pathophysiology, Medical School, National University Athens, Greece

Three hundred patients with primary Sjögren's syndrome (pSS) were investigated for liver involvement using clinical, biochemical, immunological and histological data.

Seven percent of patients showed evidence of liver disease either subclinical (2%) or asymptomatic (5%) with elevated liver enzymes In 6.6 % of patients antimitochondrial antibodies (AMA) were detected by immunofluorescence and 27% of pSS patients showed antibodies to pyruvate dehydrogenase (a-PDH) using ELISA. AMA-positive patients were further investigated with transcutaneous liver biopsy. Ninety-two per cent of patients with AMA showed liver involvement with features of chronic cholangitis similar to stage I primary biliary cirrhosis It is concluded that liver involvement in pSS patients is rare and subclinical with histological features predominantly of stage I primary biliary cirrhosis AMA is the most sensitive indicator of underlying liver pathology in pSS patients

KEY WORDS: Sjögren's syndrome, Antimitochondrial antibodies, Primary biliary cirrhosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
C. Salliot, L. Mouthon, M. Ardizzone, J. Sibilia, L. Guillevin, J.-E. Gottenberg, and X. Mariette
Sjogren's syndrome is associated with and not secondary to systemic sclerosis
Rheumatology, February 1, 2007; 46(2): 321 - 326.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
S Abraham, S Begum, and D Isenberg
Hepatic manifestations of autoimmune rheumatic diseases
Ann Rheum Dis, February 1, 2004; 63(2): 123 - 129.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S. A. PAPIRIS, M. SAETTA, G. TURATO, R. LA CORTE, L. TREVISANI, C. E. MAPP, P. MAESTRELLI, L. M. FABBRI, and A. POTENA
CD4-Positive T-Lymphocytes Infiltrate the Bronchial Mucosa of Patients with Sjogren's Syndrome
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 637 - 641.
[Abstract] [Full Text]

Home page
 LupusHome page
G. Linardaki, F. Skopouli, C. Koufos, and H. Moutsopoulos
Subclinical multisystemic autoimmunity presenting as a progressive myelopathy
Lupus, January 1, 1997; 6(8): 675 - 677.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.